Milestone Pharmaceuticals, Inc. (MIST)
1.42
-0.02
(-1.39%)
USD |
NASDAQ |
May 29, 16:00
1.43
+0.01
(+0.70%)
After-Hours: 20:00
Milestone Pharmaceuticals Total Liabilities (Quarterly) : 157.68M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | 2.242M |
| NervGen Pharma Corp. | 10.91M |
| Manzo Pharmaceuticals, Inc. | -- |
| Clearmind Medicine, Inc. | 2.905M |
| Pharmagreen Biotech, Inc. | 9.943M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 193.73M |
| Shareholders Equity (Quarterly) | 36.05M |
| Debt to Equity Ratio | 3.810 |
| Current Ratio | 9.179 |
| Net Debt Paydown Yield | -11.78% |